VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 209 filers reported holding VIR BIOTECHNOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $422,962 | -68.4% | 45,140 | -17.4% | 0.00% | -100.0% |
| Q2 2023 | $1,339,853 | +86.5% | 54,621 | +76.9% | 0.00% | – |
| Q1 2023 | $718,438 | -7.2% | 30,874 | +0.9% | 0.00% | – |
| Q4 2022 | $774,334 | +33.7% | 30,594 | +1.9% | 0.00% | – |
| Q3 2022 | $578,978 | -25.8% | 30,030 | -2.0% | 0.00% | -100.0% |
| Q2 2022 | $780,732 | -35.9% | 30,653 | -35.1% | 0.00% | 0.0% |
| Q1 2022 | $1,218,526 | -6.3% | 47,223 | +50.2% | 0.00% | 0.0% |
| Q4 2021 | $1,301,000 | -5.9% | 31,448 | -1.0% | 0.00% | 0.0% |
| Q3 2021 | $1,382,000 | -16.0% | 31,763 | -8.8% | 0.00% | 0.0% |
| Q2 2021 | $1,646,000 | +2.9% | 34,822 | +11.6% | 0.00% | 0.0% |
| Q1 2021 | $1,599,000 | +80.3% | 31,196 | -5.9% | 0.00% | 0.0% |
| Q4 2020 | $887,000 | -18.5% | 33,137 | +4.6% | 0.00% | 0.0% |
| Q3 2020 | $1,088,000 | +4.0% | 31,687 | +10.0% | 0.00% | 0.0% |
| Q2 2020 | $1,046,000 | +360.8% | 28,807 | +335.7% | 0.00% | – |
| Q1 2020 | $227,000 | – | 6,611 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
| Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
| Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
| Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
| DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
| SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
| Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
| BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
| SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |